- According to Transparency Market Research’s latest report on the global Alpha 1 Antitrypsin Deficiency Treatment market for the historical period 2017–2018 and forecast period 2019–2027, rising incidence & prevalence of respiratory diseases and growing awareness for alpha 1 antitrypsin (AAT) deficiency are projected to drive the global Alpha 1 Antitrypsin Deficiency Treatment market during the forecast period
- According to the report, the global Alpha 1 Antitrypsin Deficiency Treatment market was valued at US$ 1.4 Bn in 2018 and is anticipated to grow at a CAGR of 10.1% from 2019 to 2027
Request Brochure for Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=13214
Rising incidence and prevalence of respiratory diseases across the globe: Key Driver
- High prevalence and rise in incidence rate of respiratory diseases across the globe is a key factor driving the global Alpha 1 Antitrypsin deficiency treatment market.
- For instance, according the World Health Organization (WHO), every year, around 65 million people suffer from chronic obstructive pulmonary disease (COPD) and 3 million die due to this disease worldwide.
- Furthermore, awareness for AAT deficiency in developing regions is also fuelling the growth of global Alpha 1 Antitrypsin deficiency treatment market.
- Moreover growing government initiatives for increasing blood and plasma products and rise in prescription of combination therapies are also contributed for the growth of global market.
Request for Analysis of COVID19 Impact on Alpha 1 Antitrypsin Deficiency Treatment Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=13214
Side effects and complications related to Alpha 1 Antitrypsin Deficiency Treatment products hamper the market growth
- Treatment of Alpha 1 Antitrypsin deficiency may cause some serious side effects such as back pain, chest pain, rhinorrhea, sinusitis which can hamper the market growth.
- High cost of therapy and lesser diagnosis rate for the disease are also some of the factors which can adversely affect the market growth.
Global Alpha 1 Antitrypsin Deficiency Treatment Market: North America dominated the global market
- On the basis of region, the Alpha 1 Antitrypsin Deficiency Treatment market is segmented as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.
- North America region dominated the global market owing to higher prevalence of respiratory diseases in the region, higher R&D investment funding by major companies, and better diagnosis rate for AAT deficiency.
- However, Europe region is considered as the most lucrative market during the forecast period from 2019 to 2027. The growth is mainly ascribed to factors such as growing aging population which is more prone to respiratory diseases, growing awareness & product demand of Alpha 1 Antitrypsin Deficiency Treatment, and rising research & development for respiratory disease treatment.
Buy Market Report – https://www.transparencymarketresearch.com/checkout.php?rep_id=13214<ype=S
Global Alpha 1 Antitrypsin Deficiency Treatment Market: Competitive Landscape
- This report profiles major players in the global Alpha 1 Antitrypsin deficiency treatment market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
- The global Alpha 1 Antitrypsin Deficiency Treatment market is highly consolidated, with a few global players accounting for a major share in market.
- Leading players operating in the global Alpha 1 Antitrypsin Deficiency Treatment market are
- Grifols, S.A
- Takeda Pharmaceutical Company Limited
- CSL Behring
- Kamada Pharmaceuticals
- GlaxoSmithKline Plc.
- AstraZeneca
- Boehringer Ingelheim GmbH
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- LFB Biomedicaments S.A.?
About Us
Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
